Endo Tools Therapeutics

Endo Tools Therapeutics

Private
BelgiumHealthcare & Life Scienceshttps://www.endotools.be/

Last Round

Series D

Jan 19, 2021

Total Funding Raised

$15.2M

Momentum Score

25 /100

Company Overview

Endo Tools Therapeutics is a medical device company that develops and markets innovative, minimally invasive endoscopic solutions for gastroenterologists.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

therapeutic endoscopyendoscopic suturingmedical devicetriangulation platformincisionless surgerygastroenterology devicesendoscopic gastroplastyminimally invasive surgerytissue approximationNOTESnatural orifice surgerysurgical endoscopybariatric endoscopyendoluminal surgeryfull-thickness suturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endo Tools Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Endo Tools Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJan 19, 2021
Series CFeb 11, 2019
VC RoundSep 11, 2013

Key People

Founding team and executive leadership

Alexandre Chau

CEO

Executive Team

Nicolas De Bie

CFO

Executive Team

Endo Tools Therapeutics Investors

Notable investors and investment history

InvestorRounds
Federal Holding and Investment CompanyVC Round, Series D, Series C
EpimedeSeries D, Series C
White FundSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2026

    Grew 26% QoQ from 23 to 29 employees.

  • Nov 10, 2024

    Monthly visitors increased 159% MoM.

Endo Tools Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Endo Tools Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endo Tools Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range29
Year Founded2008
Last FundingJan 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.